Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
32%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
HART
75
HOLDINGS
18%
ALSO IN HRTS
HRTS
44
HOLDINGS
27%
ALSO IN HART
SECTOR DRIFT (HART minus HRTS)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in HART |
Weight in HRTS |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 4.5% | 8.6% | 4.5% | |
ASTRAZENECA PLC | 5.9% | 4.3% | 4.3% | |
ABBOTT LABORATORIES | 5.5% | 4.2% | 4.2% | |
BOSTON SCIENTIFIC CORP | 5.8% | 3.6% | 3.6% | |
NOVARTIS AG | 6.0% | 3.2% | 3.2% |
HART Overweight Relative to HRTS
ALPHABET INC. CLASS A | 6.8% | |
APPLE INC | 4.9% | |
PFIZER INC | 4.7% | |
SANOFI-AVENTIS | 3.2% | |
NOVARTIS AG | 2.9% | |
JOHNSON & JOHNSON | 2.7% | |
NIKE INC -CL B | 2.6% | |
HCA HOLDINGS INC | 2.3% | |
BOSTON SCIENTIFIC CORP | 2.2% | |
BRISTOL-MYERS SQUIBB CO | 2.2% |
HART Underweight Relative to HRTS
UNITEDHEALTH GROUP INC | -4.9% | |
ROCHE HOLDINGS LTD-SPONS ADR | -4.3% | |
ELI LILLY & CO | -4.1% | |
GILEAD SCIENCES INC | -4.0% | |
THERMO FISHER SCIENTIFIC INC | -3.6% | |
ABBVIE INC | -3.3% | |
VERTEX PHARMACEUTICALS INC | -2.5% | |
DANAHER CORP | -2.4% | |
MERCK & CO. INC. | -2.3% | |
ARROWHEAD PHARMACEUTICALS, INC. | -2.3% |